These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 21665356)
1. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M; Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356 [TBL] [Abstract][Full Text] [Related]
2. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329 [TBL] [Abstract][Full Text] [Related]
3. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M; BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612 [TBL] [Abstract][Full Text] [Related]
11. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475 [TBL] [Abstract][Full Text] [Related]
12. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Raman JD; Ng CK; Scherr DS; Margulis V; Lotan Y; Bensalah K; Patard JJ; Kikuchi E; Montorsi F; Zigeuner R; Weizer A; Bolenz C; Koppie TM; Isbarn H; Jeldres C; Kabbani W; Remzi M; Waldert M; Wood CG; Roscigno M; Oya M; Langner C; Wolf JS; Ströbel P; Fernández M; Karakiewcz P; Shariat SF Eur Urol; 2010 Jun; 57(6):1072-9. PubMed ID: 19619934 [TBL] [Abstract][Full Text] [Related]
13. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885 [TBL] [Abstract][Full Text] [Related]
14. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662 [TBL] [Abstract][Full Text] [Related]
15. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596 [TBL] [Abstract][Full Text] [Related]
16. The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study. Berod AA; Colin P; Yates DR; Ouzzane A; Audouin M; Adam E; Arroua F; Marchand C; Bigot P; Soulié M; Roumiguié M; Polguer T; Gardic S; Grès P; Ravier E; Neuzillet Y; Delage F; Bodin T; Pignot G; Rouprêt M; BJU Int; 2012 Dec; 110(11 Pt C):E1035-40. PubMed ID: 22568669 [TBL] [Abstract][Full Text] [Related]
17. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours. Bin X; Roy OP; Ghiraldi E; Manglik N; Liang T; Vira M; Kavoussi LR BJU Int; 2012 Dec; 110(11 Pt B):E514-9. PubMed ID: 22578024 [TBL] [Abstract][Full Text] [Related]
18. Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria. Zhang X; Zhu Z; Zhong S; Xu T; Shen Z World J Urol; 2013 Feb; 31(1):155-60. PubMed ID: 22614444 [TBL] [Abstract][Full Text] [Related]
19. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378 [TBL] [Abstract][Full Text] [Related]
20. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]